Bedside calculation of stroke risk in patients with atrial fibrillation.
Sprague
Denise
D
Pharmaceutical Sciences Clinical Service Unit, Vancouver Hospital and Health Sciences Centre, University of British Columbia, 2211 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 2B5.
Loewen
Peter
P
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications*; D002986:Clinical Trials as Topic; D034201:Computers, Handheld; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D019095:Point-of-Care Systems; D011237:Predictive Value of Tests; D012307:Risk Factors; D012984:Software; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin